5 Followers on Owler
XyloCor is a Pennsylvania-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of cardiovascular diseases...
Read moreXyloCor is a Pennsylvania-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of cardiovascular diseases...
Read more
News
Jan 27, 2023
Clinical Trials Arena
XyloCor: XyloCor reports positive data from refractory angina gene therapy trial
Jan 26, 2023
Endpoints News
XyloCor: XyloCor wraps up PhII for heart disease gene therapy, plans for pivotal trial
Jun 28, 2022
Business Wire
Press Release: XyloCor : XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease
May 18, 2022
FirstWord Pharma
XyloCor: XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT
Jan 18, 2022
Citybizlist
XyloCor: XyloCor Therapeutics Appoint Elizabeth Tarka, M.D. as Chief Medical Officer and A. Brian Davis as Chief Financial Officer
Jan 18, 2022
Business Wire
Press Release: XyloCor : XyloCor Therapeutics Expands Leadership Team with Accomplished Pharmaceutical Executives to Accelerate Clinical Development Programs and Drive Corporate Growth
Jul 28, 2021
Clinical Trials Arena
XyloCor: XyloCor begins Phase II part of EXACT trial for refractory angina
Mar 23, 2021
Venture Capital Journal
XyloCor: XyloCor Therapeutics pulls in $22.6m
Mar 22, 2021
The Business Journals: Philadelphia
XyloCor: Chester County gene therapy developer closes $41.9M funding round
Mar 22, 2021
BioSpace
XyloCor: XyloCor's Series A Expands with Additional $22.6 Million
XyloCor Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to XyloCor?
XyloCor News
XyloCor Press Releases
XyloCor Headquarters
XyloCor Summary
ABOUT
Overview
XyloCor is a Pennsylvania-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of cardiovascular diseases. XyloCor was founded in 2013. XyloCor's headquarters is located in Wayne, Pennsylvania, USA 19087. ...CEO
XyloCor's President & CEO, Albert Gianchetti, currently has an approval rating of 90%. XyloCor's primary competitors are HeartFlow, Verve & Cardurion.Website
xylocor.comCompetitors
View 13 XyloCor competitors here.Acquisitions
There have been no acquisitions found related to XyloCorInvestments
Recent investment data cannot be found related to XyloCorFrequently Asked Questions about XyloCor
When was XyloCor founded?
XyloCor was founded in 2013Who is XyloCor's CEO?
XyloCor's CEO is Albert GianchettiHow much revenue does XyloCor generate?
XyloCor generates $5.1M in revenueHow much funding does XyloCor have?
XyloCor has historically raised $42.6M in funding
Where is XyloCor's headquarters?
XyloCor's headquarters is in Wayne Pennsylvania, USAHow many employees does XyloCor have?
XyloCor has 20 employeesWhat sector does XyloCor operate in?
XyloCor is in Pharmaceuticals, BiotechnologyWho are XyloCor's competitors?
XyloCor's top competitors are HeartFlow, Verve, Cardurion